Information Provided By: 
Fly News Breaks for April 27, 2018
EXAS
Apr 27, 2018 | 07:45 EDT
Canaccord analyst Mark Massaro raised his price target on Exact Sciences to $60 from $55 following strong Q1 results. The analyst noted its solid results came despite severe weather and a heavy flu season, which he believes is a testimony to the company's solid execution. He noted the company did not raise guidance, but he views that as it being conservative. Massaro reiterated his Buy rating on Exact Sciences shares.
News For EXAS From the Last 2 Days
There are no results for your query EXAS
